Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV
NCT00842634
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
HIV
HIV Infections
Interventions
BIOLOGICAL:
ZFN modified T cells
OTHER:
Structured Treatment Interruption
Sponsor
University of Pennsylvania
Collaborators
[object Object]